Vertex Pharmaceuticals earnings: what to look for from VRTX
Published . Updated .
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results this Monday after market close. Here’s what to expect.
Directly affected
- VRTX Vertex Pharmaceuticals Inc / Ma+9.5% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VRTX | -7.41% | -5.21% | base | after close | after close | after close | after close |
| XLV | -3.03% | -2.77% | base | after close | after close | after close | after close |
| XBI | -3.49% | +0.99% | base | after close | after close | after close | after close |
| LLY | -9.71% | -8.92% | base | after close | after close | after close | after close |
| JNJ | -2.53% | -0.72% | base | after close | after close | after close | after close |
| PFE | -2.33% | -3.34% | base | after close | after close | after close | after close |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Vertex Pharmaceuticals earnings: what to look for from VRTX Yahoo Finance
Source: Yahoo Finance
Select Sector Spdr Tr (XLV) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | -0.72% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.53% | final price |
| Eli Lilly (LLY) | three days earlier | -8.92% | final price |
| Eli Lilly (LLY) | five days earlier | -9.71% | final price |
| Pfizer (PFE) | three days earlier | -3.34% | final price |
| Pfizer (PFE) | five days earlier | -2.33% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | three days earlier | -5.21% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | five days earlier | -7.41% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.99% | final price |
| Spdr Series Trust (XBI) | five days earlier | -3.49% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.77% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.03% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Vertex Pharmaceuticals Inc / Ma (VRTX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. David J. Taylor sold Vertex Pharmaceuticals Inc / Ma (VRTX), worth $1,001 - $15,000 on 26 Aug 2026. That is 68 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies carried with this story
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “Vertex Pharmaceuticals earnings: what to look for from VRTX.” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “Vertex Pharmaceuticals earnings: what to look for from VRTX.” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
In “Vertex Pharmaceuticals earnings: what to look for from VRTX,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- VRTX Vertex Pharmaceuticals Inc / Ma
For “Vertex Pharmaceuticals earnings: what to look for from VRTX,” Vertex Pharmaceuticals Inc / Ma (VRTX) is linked, with no stored direction, medium confidence. Reason on file: Vertex Pharmaceuticals (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
For “Vertex Pharmaceuticals earnings: what to look for from VRTX,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
In “Vertex Pharmaceuticals earnings: what to look for from VRTX,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “Vertex Pharmaceuticals earnings: what to look for from VRTX” reaches Select Sector Spdr Tr (XLV)
The 2 Nov 2026 story “Vertex Pharmaceuticals earnings: what to look for from VRTX” names Select Sector Spdr Tr (XLV) because of this story.
For Select Sector Spdr Tr (XLV), the reason on file says Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Spdr Series Trust (XBI) is here too. Its reason reads: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Dates in the story, and the Select Sector Spdr Tr (XLV) price range
LLY traded between 1131.55 and 1447.86 across 20 sessions. The latest close on file is 1415.62.
How solid “Vertex Pharmaceuticals earnings: what to look for from VRTX” looks
46 out of 100
“Vertex Pharmaceuticals earnings: what to look for from VRTX” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.